OncoDNA Inks Contract for International Breast Cancer Study | GenomeWeb

NEW YORK (GenomeWeb) – Belgian personalized cancer firm OncoDNA said today it has been awarded a contract to conduct testing and analysis for the Breast International Group (BIG), a Brussels non-profit that funds breast cancer research.

Under the multi-year contract, OncoDNA will perform its OncoDEEP Clinical Plus test on primary and metastatic tumor and blood samples from BIG's AURORA breast cancer clinical research program, which launched on April 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.